Eightco Holdings has repurchased over 55 million shares under its $125 million buyback program, representing nearly 13% of its shares since August. The company sold a portion of its OpenAI investment at a 40% gain over its initial cost, highlighting portfolio appreciation not reflected in its reported treasury values. Proceeds from this sale will fund further share repurchases as Eightco aims to leverage its balance sheet to enhance shareholder returns while maintaining significant exposure to innovative private companies like OpenAI and Beast Industries. The company emphasizes its commitment to long-term shareholder value amid ongoing investments in AI and digital identity sectors.
Eightco Holdings' strategic monetization and buyback program is notable amid a Technology sector where only 21 of 150 US stocks traded on Pluang rose today. For readers following this sector, here is Pluang's market snapshot as of Oct 29, 2026 19:13 WIB: Zscaler Inc (ZS) traded at USD 236.40 with a 7.58% decline and 86% buy order activity, Nebius Group NV (NBIS) at USD 169.30 down 7.15% with 67% buy orders, and Okta, Inc. (OKTA) at USD 206.95 down 7.06% with 100% buy orders. Typical hold times range from 26 to 45 days.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
